急性失代偿性心力衰竭预后的时间趋势:单中心 11 年回顾性分析

IF 1.9 Q3 PERIPHERAL VASCULAR DISEASE
Gil Marcus , Mohammad Najjar , Antionette Monayer , Ady Orbach , Shiri L. Maymon , Eran Kalmanovich , Gil Moravsky , Avishay Grupper , Shmuel Fuchs , Sa'ar Minha
{"title":"急性失代偿性心力衰竭预后的时间趋势:单中心 11 年回顾性分析","authors":"Gil Marcus ,&nbsp;Mohammad Najjar ,&nbsp;Antionette Monayer ,&nbsp;Ady Orbach ,&nbsp;Shiri L. Maymon ,&nbsp;Eran Kalmanovich ,&nbsp;Gil Moravsky ,&nbsp;Avishay Grupper ,&nbsp;Shmuel Fuchs ,&nbsp;Sa'ar Minha","doi":"10.1016/j.ijcrp.2024.200306","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Acute Decompensated Heart Failure (ADHF) is associated with frequent hospitalizations, posing a significant health and economic burden globally. Despite advancements in heart failure management, studies delineating temporal trends in ADHF outcomes are sparse.</p><p>Methods: in this retrospective analysis, ADHF patients admitted to Shamir Medical Center from 2007 to 2017 were categorized into two cohorts: early (2007–2011) and recent (2012–2017). Clinical characteristics, in-hospital interventions, and outcomes were compared. Survival analysis was performed using Kaplan-Meier methods with log-rank tests.</p></div><div><h3>Results</h3><p>8332 admitted patients were analyzed, 4366 (52.4 %) in the early period, and 3966 (47.6 %) in the recent period. In the recent cohort, ischemic heart disease decreased significantly (from 45.2 % to 34.7 %), while hypertension and smoking rates increased. Additionally, a significant increase in coronary artery bypass grafting (from 0.8 % to 3.5 %) and beta-blockers prescription (from 45.5 % to 63.4 %) post-discharge was observed. However, no substantial improvement in in-hospital mortality (8.9 % in early vs. 8.0 % in recent), 30-day (3.2 % in early vs. 3.1 % in recent), 1-year (23.3 % in early vs. 23.8 % in recent), or 5-year survival rates was noted between cohorts. A subset analysis of patients admitted to cardiology departments showed a significant reduction in in-hospital mortality in the recent cohort (12.3 % in early vs. 6.3 % in recent), yet without a corresponding long-term survival benefit.</p></div><div><h3>Conclusions</h3><p>Advancements in heart failure management over the 11-year study period did not demonstrate an improvement in clinical outcomes for ADHF patients, highlighting the challenge of translating advancements in the medical care of ADHF patients into long-term survival benefits.</p></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"22 ","pages":"Article 200306"},"PeriodicalIF":1.9000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772487524000710/pdfft?md5=d39564b9ef9ea497e9696c75470623e1&pid=1-s2.0-S2772487524000710-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Temporal trends in acute decompensated heart failure outcomes: A single-center 11-year retrospective analysis\",\"authors\":\"Gil Marcus ,&nbsp;Mohammad Najjar ,&nbsp;Antionette Monayer ,&nbsp;Ady Orbach ,&nbsp;Shiri L. Maymon ,&nbsp;Eran Kalmanovich ,&nbsp;Gil Moravsky ,&nbsp;Avishay Grupper ,&nbsp;Shmuel Fuchs ,&nbsp;Sa'ar Minha\",\"doi\":\"10.1016/j.ijcrp.2024.200306\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Acute Decompensated Heart Failure (ADHF) is associated with frequent hospitalizations, posing a significant health and economic burden globally. Despite advancements in heart failure management, studies delineating temporal trends in ADHF outcomes are sparse.</p><p>Methods: in this retrospective analysis, ADHF patients admitted to Shamir Medical Center from 2007 to 2017 were categorized into two cohorts: early (2007–2011) and recent (2012–2017). Clinical characteristics, in-hospital interventions, and outcomes were compared. Survival analysis was performed using Kaplan-Meier methods with log-rank tests.</p></div><div><h3>Results</h3><p>8332 admitted patients were analyzed, 4366 (52.4 %) in the early period, and 3966 (47.6 %) in the recent period. In the recent cohort, ischemic heart disease decreased significantly (from 45.2 % to 34.7 %), while hypertension and smoking rates increased. Additionally, a significant increase in coronary artery bypass grafting (from 0.8 % to 3.5 %) and beta-blockers prescription (from 45.5 % to 63.4 %) post-discharge was observed. However, no substantial improvement in in-hospital mortality (8.9 % in early vs. 8.0 % in recent), 30-day (3.2 % in early vs. 3.1 % in recent), 1-year (23.3 % in early vs. 23.8 % in recent), or 5-year survival rates was noted between cohorts. A subset analysis of patients admitted to cardiology departments showed a significant reduction in in-hospital mortality in the recent cohort (12.3 % in early vs. 6.3 % in recent), yet without a corresponding long-term survival benefit.</p></div><div><h3>Conclusions</h3><p>Advancements in heart failure management over the 11-year study period did not demonstrate an improvement in clinical outcomes for ADHF patients, highlighting the challenge of translating advancements in the medical care of ADHF patients into long-term survival benefits.</p></div>\",\"PeriodicalId\":29726,\"journal\":{\"name\":\"International Journal of Cardiology Cardiovascular Risk and Prevention\",\"volume\":\"22 \",\"pages\":\"Article 200306\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2772487524000710/pdfft?md5=d39564b9ef9ea497e9696c75470623e1&pid=1-s2.0-S2772487524000710-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Cardiology Cardiovascular Risk and Prevention\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772487524000710\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cardiology Cardiovascular Risk and Prevention","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772487524000710","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

背景急性失代偿性心力衰竭(ADHF)与频繁住院有关,在全球范围内造成了巨大的健康和经济负担。方法:在这项回顾性分析中,2007 年至 2017 年入住沙米尔医疗中心的 ADHF 患者被分为两个队列:早期队列(2007-2011 年)和近期队列(2012-2017 年)。比较了临床特征、院内干预和预后。结果分析了 8332 名入院患者,其中早期患者 4366 人(52.4%),近期患者 3966 人(47.6%)。在近期组群中,缺血性心脏病患者明显减少(从 45.2% 降至 34.7%),而高血压和吸烟率则有所上升。此外,还观察到出院后冠状动脉旁路移植术(从 0.8% 增加到 3.5%)和β-受体阻滞剂处方率(从 45.5% 增加到 63.4%)明显增加。不过,不同组别之间的院内死亡率(早期为 8.9%,近期为 8.0%)、30 天死亡率(早期为 3.2%,近期为 3.1%)、1 年存活率(早期为 23.3%,近期为 23.8%)或 5 年存活率均无显著改善。对心脏科住院患者的子集分析显示,近期队列的院内死亡率显著降低(早期为12.3%,近期为6.3%),但长期生存率却没有相应的改善。结论在11年的研究期间,心衰管理的进步并没有改善ADHF患者的临床预后,这凸显了将ADHF患者医疗护理的进步转化为长期生存率的挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Temporal trends in acute decompensated heart failure outcomes: A single-center 11-year retrospective analysis

Background

Acute Decompensated Heart Failure (ADHF) is associated with frequent hospitalizations, posing a significant health and economic burden globally. Despite advancements in heart failure management, studies delineating temporal trends in ADHF outcomes are sparse.

Methods: in this retrospective analysis, ADHF patients admitted to Shamir Medical Center from 2007 to 2017 were categorized into two cohorts: early (2007–2011) and recent (2012–2017). Clinical characteristics, in-hospital interventions, and outcomes were compared. Survival analysis was performed using Kaplan-Meier methods with log-rank tests.

Results

8332 admitted patients were analyzed, 4366 (52.4 %) in the early period, and 3966 (47.6 %) in the recent period. In the recent cohort, ischemic heart disease decreased significantly (from 45.2 % to 34.7 %), while hypertension and smoking rates increased. Additionally, a significant increase in coronary artery bypass grafting (from 0.8 % to 3.5 %) and beta-blockers prescription (from 45.5 % to 63.4 %) post-discharge was observed. However, no substantial improvement in in-hospital mortality (8.9 % in early vs. 8.0 % in recent), 30-day (3.2 % in early vs. 3.1 % in recent), 1-year (23.3 % in early vs. 23.8 % in recent), or 5-year survival rates was noted between cohorts. A subset analysis of patients admitted to cardiology departments showed a significant reduction in in-hospital mortality in the recent cohort (12.3 % in early vs. 6.3 % in recent), yet without a corresponding long-term survival benefit.

Conclusions

Advancements in heart failure management over the 11-year study period did not demonstrate an improvement in clinical outcomes for ADHF patients, highlighting the challenge of translating advancements in the medical care of ADHF patients into long-term survival benefits.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.00
自引率
0.00%
发文量
0
审稿时长
72 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信